Author

Tobias Schwerd

MEDICAL TREATMENT OF VEO-IBD EXPOSES CHILDREN TO CRITICAL EXCIPIENTS – RESULTS FROM A RETROSPECTIVE OBSERVATIONAL SINGLE CENTER ANALYSIS
MEDICAL TREATMENT OF VEO-IBD EXPOSES CHILDREN TO CRITICAL EXCIPIENTS – RESULTS FROM A RETROSPECTIVE OBSERVATIONAL SINGLE CENTER ANALYSIS

Tobias Schwerd  et al.

Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection and Other Conditions in Children: A Joint Position Paper From the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for
Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection and Other Conditions in Children: A Joint Position Paper From the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for

Tobias Schwerd  et al.

EXCLUSIVE ENTERAL NUTRITION DRIVES PROTECTIVE MICROBIOME MODULATION IN PEDIATRIC CROHN’S DISEASE
EXCLUSIVE ENTERAL NUTRITION DRIVES PROTECTIVE MICROBIOME MODULATION IN PEDIATRIC CROHN’S DISEASE

Tobias Schwerd  et al.

DIET CONTROLS SEGMENTED FILAMENTOUS BACTERIA IN DRIVING CROHN’S DISEASE-LIKE ILEO-COLONIC INFLAMMATION IN TNFDELTAARE MICE
DIET CONTROLS SEGMENTED FILAMENTOUS BACTERIA IN DRIVING CROHN’S DISEASE-LIKE ILEO-COLONIC INFLAMMATION IN TNFDELTAARE MICE

Tobias Schwerd  et al.

THERAPEUTIC TARGETS IN PAEDIATRIC IBD: A RETROSPECTIVE ANALYSIS OF INTERMEDIATE GOALS BASED ON UPDATED STRIDE-II (SELECTING THERAPEUTIC TARGETS IN INFLAMMATORY BOWEL DISEASE) RECOMMENDATIONS
THERAPEUTIC TARGETS IN PAEDIATRIC IBD: A RETROSPECTIVE ANALYSIS OF INTERMEDIATE GOALS BASED ON UPDATED STRIDE-II (SELECTING THERAPEUTIC TARGETS IN INFLAMMATORY BOWEL DISEASE) RECOMMENDATIONS

Tobias Schwerd  et al.

Item 1 - 5 / 5
1